ReP USP - Resultado da busca

Parte de monografia/livro
Hepatites virais (2024)
Carrilho, Flair José
Source: Trabulsi-Alterthum: microbiologia. Unidade: FM
Assunto: HEPATITE VIRAL HUMANA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARRILHO, Flair José. Hepatites virais. Trabulsi-Alterthum: microbiologia. Tradução . Rio de Janeiro: Atheneu, 2024. . . Acesso em: 02 nov. 2024.
APA
Carrilho, F. J. (2024). Hepatites virais. In Trabulsi-Alterthum: microbiologia. Rio de Janeiro: Atheneu.
NLM
Carrilho FJ. Hepatites virais. In: Trabulsi-Alterthum: microbiologia. Rio de Janeiro: Atheneu; 2024. [citado 2024 nov. 02 ]
Vancouver
Carrilho FJ. Hepatites virais. In: Trabulsi-Alterthum: microbiologia. Rio de Janeiro: Atheneu; 2024. [citado 2024 nov. 02 ]
Parte de monografia/livro
Estadiamento e tratamento não cirúrgico do carcinoma hepatocelular (2024)
Chagas, Aline Lopes; Carrilho, Flair Jose
Source: Manual de transplante hepático. Unidade: FM
Subjects: CARCINOMA HEPATOCELULAR, ESTADIAMENTO DE NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHAGAS, Aline Lopes e CARRILHO, Flair Jose. Estadiamento e tratamento não cirúrgico do carcinoma hepatocelular. Manual de transplante hepático. Tradução . São Paulo: Editora dos Editores, 2024. . . Acesso em: 02 nov. 2024.
APA
Chagas, A. L., & Carrilho, F. J. (2024). Estadiamento e tratamento não cirúrgico do carcinoma hepatocelular. In Manual de transplante hepático. São Paulo: Editora dos Editores.
NLM
Chagas AL, Carrilho FJ. Estadiamento e tratamento não cirúrgico do carcinoma hepatocelular. In: Manual de transplante hepático. São Paulo: Editora dos Editores; 2024. [citado 2024 nov. 02 ]
Vancouver
Chagas AL, Carrilho FJ. Estadiamento e tratamento não cirúrgico do carcinoma hepatocelular. In: Manual de transplante hepático. São Paulo: Editora dos Editores; 2024. [citado 2024 nov. 02 ]
Artigo de periodico
BRAZILIAN SOCIETY OF HEPATOLOGY UPDATED RECOMMENDATIONS FOR SYSTEMIC TREATMENT OF HEPATOCELLULAR CARCINOMA (2023)
Chagas, Aline Lopes; Leal, Cassia Regina Guedes; Mello, Vivianne Barreto de; Barros, Fábio Marinho Do Rego; Bittencourt, Paulo Lisboa; Mattos, Angelo A; Aroucha, Dayse; Fonseca, Leonardo Gomes da ; Silva, Joyce Roma Lucas de; Dottori, Mariana Fonseca; Pessôa, Mário Guimarães ; Carrilho, Flair Jose
Source: Arquivos de gastroenterologia. Unidade: FM
Subjects: CARCINOMA HEPATOCELULAR, GUIAS, GASTROENTEROLOGIA, AMÉRICA LATINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHAGAS, Aline Lopes et al. BRAZILIAN SOCIETY OF HEPATOLOGY UPDATED RECOMMENDATIONS FOR SYSTEMIC TREATMENT OF HEPATOCELLULAR CARCINOMA. Arquivos de gastroenterologia, v. 60, n. 1, p. 106-131, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/55827. Acesso em: 02 nov. 2024.
APA
Chagas, A. L., Leal, C. R. G., Mello, V. B. de, Barros, F. M. D. R., Bittencourt, P. L., Mattos, A. A., et al. (2023). BRAZILIAN SOCIETY OF HEPATOLOGY UPDATED RECOMMENDATIONS FOR SYSTEMIC TREATMENT OF HEPATOCELLULAR CARCINOMA. Arquivos de gastroenterologia, 60( 1), 106-131. doi:10.1590/s0004-2803.202301000-14
NLM
Chagas AL, Leal CRG, Mello VB de, Barros FMDR, Bittencourt PL, Mattos AA, Aroucha D, Fonseca LG da, Silva JRL de, Dottori MF, Pessôa MG, Carrilho FJ. BRAZILIAN SOCIETY OF HEPATOLOGY UPDATED RECOMMENDATIONS FOR SYSTEMIC TREATMENT OF HEPATOCELLULAR CARCINOMA [Internet]. Arquivos de gastroenterologia. 2023 ; 60( 1): 106-131.[citado 2024 nov. 02 ] Available from: https://observatorio.fm.usp.br/handle/OPI/55827
Vancouver
Chagas AL, Leal CRG, Mello VB de, Barros FMDR, Bittencourt PL, Mattos AA, Aroucha D, Fonseca LG da, Silva JRL de, Dottori MF, Pessôa MG, Carrilho FJ. BRAZILIAN SOCIETY OF HEPATOLOGY UPDATED RECOMMENDATIONS FOR SYSTEMIC TREATMENT OF HEPATOCELLULAR CARCINOMA [Internet]. Arquivos de gastroenterologia. 2023 ; 60( 1): 106-131.[citado 2024 nov. 02 ] Available from: https://observatorio.fm.usp.br/handle/OPI/55827
Artigo de periodico
Lysosomal acid lipase deficiency in the etiological investigation of cryptogenic liver disease in adults: a multicenter brazilian study (2023)
Candolo, Aline Coelho Rocha; Cancado, Guilherme Grossi Lopes; Zitelli, Patricia Momoyo; Mazo, Daniel Ferraz de Campos; Oliveira, Claudia Pinto Marques Souza de ; Cunha-Silva, Marlone; Greca, Raquel Dias; Araujo, Roberta Chaves; Farias, Alberto Queiroz ; Carrilho, Flair Jose
Source: Gastroenterology insights. Unidade: FM
Subjects: ESTUDOS MULTICÊNTRICOS, ENZIMAS, ADULTOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CANDOLO, Aline Coelho Rocha et al. Lysosomal acid lipase deficiency in the etiological investigation of cryptogenic liver disease in adults: a multicenter brazilian study. Gastroenterology insights, v. 14, n. 4, p. 564-574, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/57940. Acesso em: 02 nov. 2024.
APA
Candolo, A. C. R., Cancado, G. G. L., Zitelli, P. M., Mazo, D. F. de C., Oliveira, C. P. M. S. de, Cunha-Silva, M., et al. (2023). Lysosomal acid lipase deficiency in the etiological investigation of cryptogenic liver disease in adults: a multicenter brazilian study. Gastroenterology insights, 14( 4), 564-574. doi:10.3390/gastroent14040040
NLM
Candolo ACR, Cancado GGL, Zitelli PM, Mazo DF de C, Oliveira CPMS de, Cunha-Silva M, Greca RD, Araujo RC, Farias AQ, Carrilho FJ. Lysosomal acid lipase deficiency in the etiological investigation of cryptogenic liver disease in adults: a multicenter brazilian study [Internet]. Gastroenterology insights. 2023 ; 14( 4): 564-574.[citado 2024 nov. 02 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57940
Vancouver
Candolo ACR, Cancado GGL, Zitelli PM, Mazo DF de C, Oliveira CPMS de, Cunha-Silva M, Greca RD, Araujo RC, Farias AQ, Carrilho FJ. Lysosomal acid lipase deficiency in the etiological investigation of cryptogenic liver disease in adults: a multicenter brazilian study [Internet]. Gastroenterology insights. 2023 ; 14( 4): 564-574.[citado 2024 nov. 02 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57940
Artigo de periodico
Liver elastography can predict degree of advanced fibrosis for autoimmune hepatitis in biochemical remission (2023)
Paranaguá-Vezozzo, Denise Cerqueira ; Terrabuio, Débora Raquel Benedita ; Pereira, Gleicy Luz Reinoso ; Moutinho, Renata; Ono, Suzane Kioko ; Salas, Veronica Walwyn; França, Joao Italo Dias ; Cançado, Eduardo Luiz Rachid ; Carrilho, Flair José ; Alves, Venancio Avancini Ferreira
Source: Jgh open. Unidade: FM
Subjects: ULTRASSONOGRAFIA, HEPATITE AUTOIMUNE, CIRROSE HEPÁTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PARANAGUÁ-VEZOZZO, Denise Cerqueira et al. Liver elastography can predict degree of advanced fibrosis for autoimmune hepatitis in biochemical remission. Jgh open, v. 7, n. 4, p. 272-277, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/53912. Acesso em: 02 nov. 2024.
APA
Paranaguá-Vezozzo, D. C., Terrabuio, D. R. B., Pereira, G. L. R., Moutinho, R., Ono, S. K., Salas, V. W., et al. (2023). Liver elastography can predict degree of advanced fibrosis for autoimmune hepatitis in biochemical remission. Jgh open, 7( 4), 272-277. doi:10.1002/jgh3.12865
NLM
Paranaguá-Vezozzo DC, Terrabuio DRB, Pereira GLR, Moutinho R, Ono SK, Salas VW, França JID, Cançado ELR, Carrilho FJ, Alves VAF. Liver elastography can predict degree of advanced fibrosis for autoimmune hepatitis in biochemical remission [Internet]. Jgh open. 2023 ; 7( 4): 272-277.[citado 2024 nov. 02 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53912
Vancouver
Paranaguá-Vezozzo DC, Terrabuio DRB, Pereira GLR, Moutinho R, Ono SK, Salas VW, França JID, Cançado ELR, Carrilho FJ, Alves VAF. Liver elastography can predict degree of advanced fibrosis for autoimmune hepatitis in biochemical remission [Internet]. Jgh open. 2023 ; 7( 4): 272-277.[citado 2024 nov. 02 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53912
Artigo de periodico
P53 and VEGF are promising biomarkers for sorafenib efficacy in an experimental model of NASH-related HCC (2023)
Nassar-Reis, Joao Pedro; Umeta, Pedro Fukui ; Stefano, José Tadeu ; Longatto Filho, Adhemar ; Carrilho, Flair José ; Alves, Venancio Avancini Ferreira ; Cogliati, Bruno ; Oliveira, Claudia Pinto Marques Souza de
Source: Journal of molecular histology. Unidades: FM, FMVZ
Subjects: MODELOS ANIMAIS, NEOPLASIAS HEPÁTICAS, INIBIDORES DE ENZIMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NASSAR-REIS, Joao Pedro et al. P53 and VEGF are promising biomarkers for sorafenib efficacy in an experimental model of NASH-related HCC. Journal of molecular histology, v. 54, n. 5, p. 473-488, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/57413. Acesso em: 02 nov. 2024.
APA
Nassar-Reis, J. P., Umeta, P. F., Stefano, J. T., Longatto Filho, A., Carrilho, F. J., Alves, V. A. F., et al. (2023). P53 and VEGF are promising biomarkers for sorafenib efficacy in an experimental model of NASH-related HCC. Journal of molecular histology, 54( 5), 473-488. doi:10.1007/s10735-023-10142-9
NLM
Nassar-Reis JP, Umeta PF, Stefano JT, Longatto Filho A, Carrilho FJ, Alves VAF, Cogliati B, Oliveira CPMS de. P53 and VEGF are promising biomarkers for sorafenib efficacy in an experimental model of NASH-related HCC [Internet]. Journal of molecular histology. 2023 ; 54( 5): 473-488.[citado 2024 nov. 02 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57413
Vancouver
Nassar-Reis JP, Umeta PF, Stefano JT, Longatto Filho A, Carrilho FJ, Alves VAF, Cogliati B, Oliveira CPMS de. P53 and VEGF are promising biomarkers for sorafenib efficacy in an experimental model of NASH-related HCC [Internet]. Journal of molecular histology. 2023 ; 54( 5): 473-488.[citado 2024 nov. 02 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57413
Artigo de periodico-carta/editorial
Current landscape and future directions for systemic treatments of hepatocellular carcinoma.[Editorial] (2023)
Fonseca, Leonardo G; Carrilho, Flair José
Source: Hepatoma research. Unidade: FM
Subjects: NEOPLASIAS HEPÁTICAS, CARCINOMA HEPATOCELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FONSECA, Leonardo G e CARRILHO, Flair José. Current landscape and future directions for systemic treatments of hepatocellular carcinoma.[Editorial]. Hepatoma research. Alhambra: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://observatorio.fm.usp.br/handle/OPI/56090. Acesso em: 02 nov. 2024. , 2023
APA
Fonseca, L. G., & Carrilho, F. J. (2023). Current landscape and future directions for systemic treatments of hepatocellular carcinoma.[Editorial]. Hepatoma research. Alhambra: Faculdade de Medicina, Universidade de São Paulo. doi:10.20517/2394-5079.2023.63
NLM
Fonseca LG, Carrilho FJ. Current landscape and future directions for systemic treatments of hepatocellular carcinoma.[Editorial] [Internet]. Hepatoma research. 2023 ; 9[citado 2024 nov. 02 ] Available from: https://observatorio.fm.usp.br/handle/OPI/56090
Vancouver
Fonseca LG, Carrilho FJ. Current landscape and future directions for systemic treatments of hepatocellular carcinoma.[Editorial] [Internet]. Hepatoma research. 2023 ; 9[citado 2024 nov. 02 ] Available from: https://observatorio.fm.usp.br/handle/OPI/56090
Artigo de periodico
Early variation of inflammatory indexes refines prognostic prediction in patients with hepatocellular carcinoma under systemic treatment (2023)
Fonseca, Leonardo Gomes da ; Uratani, Lucas Fernando; Soares, Gabriella Fernandes; Amaral, Paulo Siqueira do; Alencar, Regiane Saraiva de Souza Melo; Chagas, Aline Lopes; Alves, Venancio Avancini Ferreira ; Carrilho, Flair José
Source: Molecular and clinical oncology. Unidade: FM
Subjects: NEOPLASIAS HEPÁTICAS, CARCINOMA HEPATOCELULAR, PROGNÓSTICO, INFLAMAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FONSECA, Leonardo Gomes da et al. Early variation of inflammatory indexes refines prognostic prediction in patients with hepatocellular carcinoma under systemic treatment. Molecular and clinical oncology, v. 18, n. 4, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/53100. Acesso em: 02 nov. 2024.
APA
Fonseca, L. G. da, Uratani, L. F., Soares, G. F., Amaral, P. S. do, Alencar, R. S. de S. M., Chagas, A. L., et al. (2023). Early variation of inflammatory indexes refines prognostic prediction in patients with hepatocellular carcinoma under systemic treatment. Molecular and clinical oncology, 18( 4). doi:10.3892/mco.2023.2625
NLM
Fonseca LG da, Uratani LF, Soares GF, Amaral PS do, Alencar RS de SM, Chagas AL, Alves VAF, Carrilho FJ. Early variation of inflammatory indexes refines prognostic prediction in patients with hepatocellular carcinoma under systemic treatment [Internet]. Molecular and clinical oncology. 2023 ; 18( 4):[citado 2024 nov. 02 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53100
Vancouver
Fonseca LG da, Uratani LF, Soares GF, Amaral PS do, Alencar RS de SM, Chagas AL, Alves VAF, Carrilho FJ. Early variation of inflammatory indexes refines prognostic prediction in patients with hepatocellular carcinoma under systemic treatment [Internet]. Molecular and clinical oncology. 2023 ; 18( 4):[citado 2024 nov. 02 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53100
Artigo de periodico
Impaired anti-HBV vaccine response in non-cirrhotic chronic HCV is not overcome by double dose regimen: randomized control trial (2023)
Medeiros, Roseane P; Terrault, Norah A; Mazo, Daniel F; Oliveira, Claudia Pinto Marques Souza de ; Dodge, Jennifer; Zitelli, Patricia M; Lopes, Marta Heloísa ; Carrilho, Flair Jose ; Pessoa, Mario G
Source: Annals of hepatology. Unidade: FM
Subjects: CIRROSE HEPÁTICA, HEPATITE CRÔNICA, VACINAS VIRAIS, VACINAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MEDEIROS, Roseane P et al. Impaired anti-HBV vaccine response in non-cirrhotic chronic HCV is not overcome by double dose regimen: randomized control trial. Annals of hepatology, v. 28, n. 2, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/52954. Acesso em: 02 nov. 2024.
APA
Medeiros, R. P., Terrault, N. A., Mazo, D. F., Oliveira, C. P. M. S. de, Dodge, J., Zitelli, P. M., et al. (2023). Impaired anti-HBV vaccine response in non-cirrhotic chronic HCV is not overcome by double dose regimen: randomized control trial. Annals of hepatology, 28( 2). doi:10.1016/j.aohep.2022.100891
NLM
Medeiros RP, Terrault NA, Mazo DF, Oliveira CPMS de, Dodge J, Zitelli PM, Lopes MH, Carrilho FJ, Pessoa MG. Impaired anti-HBV vaccine response in non-cirrhotic chronic HCV is not overcome by double dose regimen: randomized control trial [Internet]. Annals of hepatology. 2023 ; 28( 2):[citado 2024 nov. 02 ] Available from: https://observatorio.fm.usp.br/handle/OPI/52954
Vancouver
Medeiros RP, Terrault NA, Mazo DF, Oliveira CPMS de, Dodge J, Zitelli PM, Lopes MH, Carrilho FJ, Pessoa MG. Impaired anti-HBV vaccine response in non-cirrhotic chronic HCV is not overcome by double dose regimen: randomized control trial [Internet]. Annals of hepatology. 2023 ; 28( 2):[citado 2024 nov. 02 ] Available from: https://observatorio.fm.usp.br/handle/OPI/52954
Artigo de periodico
P53 and VEGF are promising biomarkers for sorafenib efficacy in an experimental model of NASH‑related HCC (2023)
Reis, João Pedro Nassar; Umeta, Pedro Fukui; Stefano, José Tadeu ; Longatto Filho, Adhemar ; Carrilho, Flair José ; Alves, Venancio Avancini Ferreira ; Cogliati, Bruno ; Oliveira, Cláudia Pinto Marques Souza de
Source: Journal of Molecular Histology. Unidades: FM, FMVZ
Subjects: CARCINOMA HEPATOCELULAR, HEPATITE, INIBIDORES DE ENZIMAS, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
REIS, João Pedro Nassar et al. P53 and VEGF are promising biomarkers for sorafenib efficacy in an experimental model of NASH‑related HCC. Journal of Molecular Histology, v. 54, p. 473-488, 2023Tradução . . Disponível em: https://doi.org/10.1007/s10735-023-10142-9. Acesso em: 02 nov. 2024.
APA
Reis, J. P. N., Umeta, P. F., Stefano, J. T., Longatto Filho, A., Carrilho, F. J., Alves, V. A. F., et al. (2023). P53 and VEGF are promising biomarkers for sorafenib efficacy in an experimental model of NASH‑related HCC. Journal of Molecular Histology, 54, 473-488. doi:10.1007/s10735-023-10142-9
NLM
Reis JPN, Umeta PF, Stefano JT, Longatto Filho A, Carrilho FJ, Alves VAF, Cogliati B, Oliveira CPMS de. P53 and VEGF are promising biomarkers for sorafenib efficacy in an experimental model of NASH‑related HCC [Internet]. Journal of Molecular Histology. 2023 ; 54 473-488.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1007/s10735-023-10142-9
Vancouver
Reis JPN, Umeta PF, Stefano JT, Longatto Filho A, Carrilho FJ, Alves VAF, Cogliati B, Oliveira CPMS de. P53 and VEGF are promising biomarkers for sorafenib efficacy in an experimental model of NASH‑related HCC [Internet]. Journal of Molecular Histology. 2023 ; 54 473-488.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1007/s10735-023-10142-9
Artigo de periodico
A multidisciplinary approach to peritoneal metastasis from hepatocellular carcinoma: clinical features, management and outcomes (2022)
Fonseca, Leonardo G. da; Leonardi, Paulo C.; Hashizume, Pedro H.; Sansone, Francesco; Saud, Lisa R.; Carrilho, Flair José ; Herman, Paulo
Source: Clinical and experimental hepatology. Unidade: FM
Subjects: CARCINOMA HEPATOCELULAR, METÁSTASE NEOPLÁSICA, PROCEDIMENTOS CIRÚRGICOS OPERATÓRIOS, PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FONSECA, Leonardo G. da et al. A multidisciplinary approach to peritoneal metastasis from hepatocellular carcinoma: clinical features, management and outcomes. Clinical and experimental hepatology, v. 8, n. 1, p. 42-48, 2022Tradução . . Disponível em: https://doi.org/10.5114/ceh.2022.114297. Acesso em: 02 nov. 2024.
APA
Fonseca, L. G. da, Leonardi, P. C., Hashizume, P. H., Sansone, F., Saud, L. R., Carrilho, F. J., & Herman, P. (2022). A multidisciplinary approach to peritoneal metastasis from hepatocellular carcinoma: clinical features, management and outcomes. Clinical and experimental hepatology, 8( 1), 42-48. doi:10.5114/ceh.2022.114297
NLM
Fonseca LG da, Leonardi PC, Hashizume PH, Sansone F, Saud LR, Carrilho FJ, Herman P. A multidisciplinary approach to peritoneal metastasis from hepatocellular carcinoma: clinical features, management and outcomes [Internet]. Clinical and experimental hepatology. 2022 ; 8( 1): 42-48.[citado 2024 nov. 02 ] Available from: https://doi.org/10.5114/ceh.2022.114297
Vancouver
Fonseca LG da, Leonardi PC, Hashizume PH, Sansone F, Saud LR, Carrilho FJ, Herman P. A multidisciplinary approach to peritoneal metastasis from hepatocellular carcinoma: clinical features, management and outcomes [Internet]. Clinical and experimental hepatology. 2022 ; 8( 1): 42-48.[citado 2024 nov. 02 ] Available from: https://doi.org/10.5114/ceh.2022.114297
Artigo de periodico
Hepatocellular carcinoma (HCC) in patients with Non-Alcoholic Fatty Liver Disease (NAFLD): screening, treatment and survival analysis in a Brazilian series (2022)
Alencar, Regiane Saraiva de Souza Melo; Oliveira, Claudia P. ; Chagas, Aline Lopes; Fonseca, Leonardo Gomes da ; Maccali, Claudia; Saud, Lisa Rodrigues da Cunha; Xerfan, Mariana Pinheiro ; Stefano, José Tadeu ; Herman, Paulo ; D'albuquerque, Luiz Augusto Carneiro
Source: Clinics. Unidade: FM
Subjects: CIRROSE HEPÁTICA, NEOPLASIAS HEPÁTICAS, CARCINOMA HEPATOCELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALENCAR, Regiane Saraiva de Souza Melo et al. Hepatocellular carcinoma (HCC) in patients with Non-Alcoholic Fatty Liver Disease (NAFLD): screening, treatment and survival analysis in a Brazilian series. Clinics, v. 77, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/50508. Acesso em: 02 nov. 2024.
APA
Alencar, R. S. de S. M., Oliveira, C. P., Chagas, A. L., Fonseca, L. G. da, Maccali, C., Saud, L. R. da C., et al. (2022). Hepatocellular carcinoma (HCC) in patients with Non-Alcoholic Fatty Liver Disease (NAFLD): screening, treatment and survival analysis in a Brazilian series. Clinics, 77. doi:10.1016/j.clinsp.2022.100097
NLM
Alencar RS de SM, Oliveira CP, Chagas AL, Fonseca LG da, Maccali C, Saud LR da C, Xerfan MP, Stefano JT, Herman P, D'albuquerque LAC. Hepatocellular carcinoma (HCC) in patients with Non-Alcoholic Fatty Liver Disease (NAFLD): screening, treatment and survival analysis in a Brazilian series [Internet]. Clinics. 2022 ; 77[citado 2024 nov. 02 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50508
Vancouver
Alencar RS de SM, Oliveira CP, Chagas AL, Fonseca LG da, Maccali C, Saud LR da C, Xerfan MP, Stefano JT, Herman P, D'albuquerque LAC. Hepatocellular carcinoma (HCC) in patients with Non-Alcoholic Fatty Liver Disease (NAFLD): screening, treatment and survival analysis in a Brazilian series [Internet]. Clinics. 2022 ; 77[citado 2024 nov. 02 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50508
Artigo de periodico
Non-Alcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: Immunohistochemical Assessment of Markers of Cancer Cell Metabolism (2022)
Granja, S. C; Longatto-Filho, A; Campos, P. B. De; Oliveira, C. P; Stefano, J. T; Martins-Filho, S. N; Chagas, A. L; Herman, Paulo ; D Albuquerque, Luiz Augusto Carneiro ; Carrilho, Flair Jose
Source: PATHOBIOLOGY. Unidade: FM
Subjects: CIRROSE HEPÁTICA, CARCINOMA HEPATOCELULAR, CÉLULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GRANJA, S. C et al. Non-Alcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: Immunohistochemical Assessment of Markers of Cancer Cell Metabolism. PATHOBIOLOGY, v. 89, n. 3, p. 157-165, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/58624. Acesso em: 02 nov. 2024.
APA
Granja, S. C., Longatto-Filho, A., Campos, P. B. D., Oliveira, C. P., Stefano, J. T., Martins-Filho, S. N., et al. (2022). Non-Alcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: Immunohistochemical Assessment of Markers of Cancer Cell Metabolism. PATHOBIOLOGY, 89( 3), 157-165. doi:10.1159/000521034
NLM
Granja SC, Longatto-Filho A, Campos PBD, Oliveira CP, Stefano JT, Martins-Filho SN, Chagas AL, Herman P, D Albuquerque LAC, Carrilho FJ. Non-Alcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: Immunohistochemical Assessment of Markers of Cancer Cell Metabolism [Internet]. PATHOBIOLOGY. 2022 ; 89( 3): 157-165.[citado 2024 nov. 02 ] Available from: https://observatorio.fm.usp.br/handle/OPI/58624
Vancouver
Granja SC, Longatto-Filho A, Campos PBD, Oliveira CP, Stefano JT, Martins-Filho SN, Chagas AL, Herman P, D Albuquerque LAC, Carrilho FJ. Non-Alcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: Immunohistochemical Assessment of Markers of Cancer Cell Metabolism [Internet]. PATHOBIOLOGY. 2022 ; 89( 3): 157-165.[citado 2024 nov. 02 ] Available from: https://observatorio.fm.usp.br/handle/OPI/58624
Artigo de periodico
Impact of Brazilian expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a multicenter study (2022)
Chagas, Aline Lopes; Mattos, Angelo A; Diniz, Marcio A; Felga, Guilherme E. G; Boin, Ilka F. S. F; Silva, Rita C. M. A; Silva, Renato F.; Alves, Venancio Avancini Ferreira ; D'albuquerque, Luiz Augusto Carneiro ; CARRILHO, Flair J.
Source: Annals of hepatology. Unidade: FM
Subjects: ESTUDOS MULTICÊNTRICOS, NEOPLASIAS HEPÁTICAS, CARCINOMA HEPATOCELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHAGAS, Aline Lopes et al. Impact of Brazilian expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a multicenter study. Annals of hepatology, v. 22, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.aohep.2020.100294. Acesso em: 02 nov. 2024.
APA
Chagas, A. L., Mattos, A. A., Diniz, M. A., Felga, G. E. G., Boin, I. F. S. F., Silva, R. C. M. A., et al. (2022). Impact of Brazilian expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a multicenter study. Annals of hepatology, 22. doi:10.1016/j.aohep.2020.100294
NLM
Chagas AL, Mattos AA, Diniz MA, Felga GEG, Boin IFSF, Silva RCMA, Silva RF, Alves VAF, D'albuquerque LAC, CARRILHO FJ. Impact of Brazilian expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a multicenter study [Internet]. Annals of hepatology. 2022 ; 22[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.aohep.2020.100294
Vancouver
Chagas AL, Mattos AA, Diniz MA, Felga GEG, Boin IFSF, Silva RCMA, Silva RF, Alves VAF, D'albuquerque LAC, CARRILHO FJ. Impact of Brazilian expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a multicenter study [Internet]. Annals of hepatology. 2022 ; 22[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.aohep.2020.100294
Artigo de periodico
Direct-acting antivirals for chronic hepatitis C treatment: The experience of two tertiary university centers in Brazil (2022)
Lourenco, Mariana Sandoval; Zitelli, Patricia Momoyo Y.; Cunha-silva, Marlone; Oliveira, Arthur Ivan N.; Oliveira, Claudia Pinto Marques Souza de ; Seva-pereira, Tiago; Carrilho, Flair Jose ; Pessoa, Mario G.; Mazo, Daniel F.
Source: World journal of hepatology. Unidade: FM
Subjects: ANTIVIRAIS, HEPATITE VIRAL HUMANA, HEPATITE CRÔNICA, CIRROSE HEPÁTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOURENCO, Mariana Sandoval et al. Direct-acting antivirals for chronic hepatitis C treatment: The experience of two tertiary university centers in Brazil. World journal of hepatology, v. 14, n. 1, 2022Tradução . . Disponível em: https://doi.org/10.4254/wjh.v14.i1.195. Acesso em: 02 nov. 2024.
APA
Lourenco, M. S., Zitelli, P. M. Y., Cunha-silva, M., Oliveira, A. I. N., Oliveira, C. P. M. S. de, Seva-pereira, T., et al. (2022). Direct-acting antivirals for chronic hepatitis C treatment: The experience of two tertiary university centers in Brazil. World journal of hepatology, 14( 1). doi:10.4254/wjh.v14.i1.195
NLM
Lourenco MS, Zitelli PMY, Cunha-silva M, Oliveira AIN, Oliveira CPMS de, Seva-pereira T, Carrilho FJ, Pessoa MG, Mazo DF. Direct-acting antivirals for chronic hepatitis C treatment: The experience of two tertiary university centers in Brazil [Internet]. World journal of hepatology. 2022 ; 14( 1):[citado 2024 nov. 02 ] Available from: https://doi.org/10.4254/wjh.v14.i1.195
Vancouver
Lourenco MS, Zitelli PMY, Cunha-silva M, Oliveira AIN, Oliveira CPMS de, Seva-pereira T, Carrilho FJ, Pessoa MG, Mazo DF. Direct-acting antivirals for chronic hepatitis C treatment: The experience of two tertiary university centers in Brazil [Internet]. World journal of hepatology. 2022 ; 14( 1):[citado 2024 nov. 02 ] Available from: https://doi.org/10.4254/wjh.v14.i1.195
Artigo de periodico
Synbiotic supplementation modulates gut microbiota, regulates β-Catenin expression and prevents weight gain in ob/ob mice: preliminary findings (2022)
Duarte, Sebastião Mauro Bezerra; Stefano, José Tadeu ; Franco, Lucas Augusto Moysés ; Martins, Roberta C; Moraes, Bruna Del Guerra de Carvalho; Barbeiro, Denise Frediani ; Oliveira, Nathalia ; Neri, JuniaMarielle Teixeira Rodrigues; Cogliati, Bruno ; Vanni, Denise Siqueira; Sabino, Ester Cerdeira ; Carrilho, Flair José ; Oliveira, Cláudia Pinto Marques Souza de
Source: International Journal of Molecular Sciences. Unidades: FM, FMVZ
Subjects: SUPLEMENTOS DIETÉTICOS, OBESIDADE, MICROBIOLOGIA MÉDICA, ENTEROBACTERIACEAE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DUARTE, Sebastião Mauro Bezerra et al. Synbiotic supplementation modulates gut microbiota, regulates β-Catenin expression and prevents weight gain in ob/ob mice: preliminary findings. International Journal of Molecular Sciences, v. 23, n. 18, p. 1-16, 2022Tradução . . Disponível em: https://doi.org/10.3390/ijms231810483. Acesso em: 02 nov. 2024.
APA
Duarte, S. M. B., Stefano, J. T., Franco, L. A. M., Martins, R. C., Moraes, B. D. G. de C., Barbeiro, D. F., et al. (2022). Synbiotic supplementation modulates gut microbiota, regulates β-Catenin expression and prevents weight gain in ob/ob mice: preliminary findings. International Journal of Molecular Sciences, 23( 18), 1-16. doi:10.3390/ijms231810483
NLM
Duarte SMB, Stefano JT, Franco LAM, Martins RC, Moraes BDG de C, Barbeiro DF, Oliveira N, Neri JMTR, Cogliati B, Vanni DS, Sabino EC, Carrilho FJ, Oliveira CPMS de. Synbiotic supplementation modulates gut microbiota, regulates β-Catenin expression and prevents weight gain in ob/ob mice: preliminary findings [Internet]. International Journal of Molecular Sciences. 2022 ; 23( 18): 1-16.[citado 2024 nov. 02 ] Available from: https://doi.org/10.3390/ijms231810483
Vancouver
Duarte SMB, Stefano JT, Franco LAM, Martins RC, Moraes BDG de C, Barbeiro DF, Oliveira N, Neri JMTR, Cogliati B, Vanni DS, Sabino EC, Carrilho FJ, Oliveira CPMS de. Synbiotic supplementation modulates gut microbiota, regulates β-Catenin expression and prevents weight gain in ob/ob mice: preliminary findings [Internet]. International Journal of Molecular Sciences. 2022 ; 23( 18): 1-16.[citado 2024 nov. 02 ] Available from: https://doi.org/10.3390/ijms231810483
Artigo de periodico
Outcome of liver cancer patients with SARS-CoV-2 infection: An International, Multicentre, Cohort Study (2022)
Munoz-martinez, Sergio; Sapena, Victor; Forner, Alejandro; Bruix, Jordi; Sanduzzi-zamparelli, Marco; Rios, Jose; Bouattour, Mohamed; El-kassas, Mohamed; Leal, Cassia R. G.; Mocan, Tudor; Carrilho, Flair Jose
Source: Liver international. Unidade: FM
Subjects: COVID-19, CARCINOMA HEPATOCELULAR, NEOPLASIAS HEPÁTICAS, MORTALIDADE, ESTUDOS DE COORTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MUNOZ-MARTINEZ, Sergio et al. Outcome of liver cancer patients with SARS-CoV-2 infection: An International, Multicentre, Cohort Study. Liver international, v. 42, n. 8, p. 1891-1901, 2022Tradução . . Disponível em: https://doi.org/10.1111/liv.15320. Acesso em: 02 nov. 2024.
APA
Munoz-martinez, S., Sapena, V., Forner, A., Bruix, J., Sanduzzi-zamparelli, M., Rios, J., et al. (2022). Outcome of liver cancer patients with SARS-CoV-2 infection: An International, Multicentre, Cohort Study. Liver international, 42( 8), 1891-1901. doi:10.1111/liv.15320
NLM
Munoz-martinez S, Sapena V, Forner A, Bruix J, Sanduzzi-zamparelli M, Rios J, Bouattour M, El-kassas M, Leal CRG, Mocan T, Carrilho FJ. Outcome of liver cancer patients with SARS-CoV-2 infection: An International, Multicentre, Cohort Study [Internet]. Liver international. 2022 ; 42( 8): 1891-1901.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1111/liv.15320
Vancouver
Munoz-martinez S, Sapena V, Forner A, Bruix J, Sanduzzi-zamparelli M, Rios J, Bouattour M, El-kassas M, Leal CRG, Mocan T, Carrilho FJ. Outcome of liver cancer patients with SARS-CoV-2 infection: An International, Multicentre, Cohort Study [Internet]. Liver international. 2022 ; 42( 8): 1891-1901.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1111/liv.15320
Artigo de periodico
Performance of pre-transplant criteria in prediction of hepatocellular carcinoma progression and waitlist dropout (2022)
Pinero, Federico; Thompson, Marcos; Boin, Ilka; Chagas, Aline; Quinonez, Emilio; Bermudez, Carla; Vilatoba, Mario; Santos, Luisa; Anders, Margarita; Duque, Sergio Hoyos; Carrilho, Flair Jose
Source: Liver international. Unidade: FM
Subjects: CARCINOMA HEPATOCELULAR, RECIDIVA, CUIDADOS PRÉ-OPERATÓRIOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PINERO, Federico et al. Performance of pre-transplant criteria in prediction of hepatocellular carcinoma progression and waitlist dropout. Liver international, v. 42, n. 8, p. 1879-1890, 2022Tradução . . Disponível em: https://doi.org/10.1111/liv.15223. Acesso em: 02 nov. 2024.
APA
Pinero, F., Thompson, M., Boin, I., Chagas, A., Quinonez, E., Bermudez, C., et al. (2022). Performance of pre-transplant criteria in prediction of hepatocellular carcinoma progression and waitlist dropout. Liver international, 42( 8), 1879-1890. doi:10.1111/liv.15223
NLM
Pinero F, Thompson M, Boin I, Chagas A, Quinonez E, Bermudez C, Vilatoba M, Santos L, Anders M, Duque SH, Carrilho FJ. Performance of pre-transplant criteria in prediction of hepatocellular carcinoma progression and waitlist dropout [Internet]. Liver international. 2022 ; 42( 8): 1879-1890.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1111/liv.15223
Vancouver
Pinero F, Thompson M, Boin I, Chagas A, Quinonez E, Bermudez C, Vilatoba M, Santos L, Anders M, Duque SH, Carrilho FJ. Performance of pre-transplant criteria in prediction of hepatocellular carcinoma progression and waitlist dropout [Internet]. Liver international. 2022 ; 42( 8): 1879-1890.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1111/liv.15223
Artigo de periodico
Two decades of liver resection with a multidisciplinary approach in a single institution: What has changed? Analysis of 1409 cases (2022)
Herman, Paulo ; Fonseca, Gilton Marques; Coelho, Fabricio Ferreira; Kruger, Jaime Arthur Pirola; Makdissi, Fabio Ferrari; Jeismann, Vagner Birk; Carrilho, Flair Jose ; D Albuquerque, Luiz Augusto Carneiro ; Nahas, Sergio Carlos
Source: Clinics. Unidade: FM
Subjects: NEOPLASIAS HEPÁTICAS, METÁSTASE NEOPLÁSICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HERMAN, Paulo et al. Two decades of liver resection with a multidisciplinary approach in a single institution: What has changed? Analysis of 1409 cases. Clinics, v. 77, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.clinsp.2022.100088. Acesso em: 02 nov. 2024.
APA
Herman, P., Fonseca, G. M., Coelho, F. F., Kruger, J. A. P., Makdissi, F. F., Jeismann, V. B., et al. (2022). Two decades of liver resection with a multidisciplinary approach in a single institution: What has changed? Analysis of 1409 cases. Clinics, 77. doi:10.1016/j.clinsp.2022.100088
NLM
Herman P, Fonseca GM, Coelho FF, Kruger JAP, Makdissi FF, Jeismann VB, Carrilho FJ, D Albuquerque LAC, Nahas SC. Two decades of liver resection with a multidisciplinary approach in a single institution: What has changed? Analysis of 1409 cases [Internet]. Clinics. 2022 ; 77[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.clinsp.2022.100088
Vancouver
Herman P, Fonseca GM, Coelho FF, Kruger JAP, Makdissi FF, Jeismann VB, Carrilho FJ, D Albuquerque LAC, Nahas SC. Two decades of liver resection with a multidisciplinary approach in a single institution: What has changed? Analysis of 1409 cases [Internet]. Clinics. 2022 ; 77[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.clinsp.2022.100088
Artigo de periodico
Non-invasive methods for iron overload evaluation in dysmetabolic patients (2022)
Branissoa, Paula Pessin Fabrega; Oliveira, Claudia Pinto Marques Souza de ; Leao Filho, Hilton Muniz; Lima, Fabiana Roberto; Santose, Aritania Sousa; Mancini, Marcio Correa; Melo, Maria Edna de; Carrilho, Flair José ; Rocha, Manoel de Souza ; Clark, Paul
Source: Annals of hepatology. Unidade: FM
Subjects: HEPATOPATIAS, IMAGEM POR RESSONÂNCIA MAGNÉTICA, DIAGNÓSTICO POR IMAGEM
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRANISSOA, Paula Pessin Fabrega et al. Non-invasive methods for iron overload evaluation in dysmetabolic patients. Annals of hepatology, v. 27, n. 4, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.aohep.2022.100707. Acesso em: 02 nov. 2024.
APA
Branissoa, P. P. F., Oliveira, C. P. M. S. de, Leao Filho, H. M., Lima, F. R., Santose, A. S., Mancini, M. C., et al. (2022). Non-invasive methods for iron overload evaluation in dysmetabolic patients. Annals of hepatology, 27( 4). doi:10.1016/j.aohep.2022.100707
NLM
Branissoa PPF, Oliveira CPMS de, Leao Filho HM, Lima FR, Santose AS, Mancini MC, Melo ME de, Carrilho FJ, Rocha M de S, Clark P. Non-invasive methods for iron overload evaluation in dysmetabolic patients [Internet]. Annals of hepatology. 2022 ; 27( 4):[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.aohep.2022.100707
Vancouver
Branissoa PPF, Oliveira CPMS de, Leao Filho HM, Lima FR, Santose AS, Mancini MC, Melo ME de, Carrilho FJ, Rocha M de S, Clark P. Non-invasive methods for iron overload evaluation in dysmetabolic patients [Internet]. Annals of hepatology. 2022 ; 27( 4):[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.aohep.2022.100707

USP Schools

ReP

Filtros

Document Types

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Publisher

Conference titles

Countries/Territories

Funding Agencies

Indexado em

Non normalized affiliation